Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 11;64(2):243-250.
eCollection 2023 Mar-Apr.

A Comparative Analysis of Laboratory Parameters of Hospitalized COVID-19 Patients by Disease Severity and Mortality at a Facility in Ibadan, Nigeria

Affiliations

A Comparative Analysis of Laboratory Parameters of Hospitalized COVID-19 Patients by Disease Severity and Mortality at a Facility in Ibadan, Nigeria

Olukemi Adekanmbi et al. Niger Med J. .

Abstract

Background: COVID-19, which is caused by the SARS-CoV-2 virus, is associated with abnormalities of biochemical parameters. There are indications that some of these biochemical parameters can differ according to the severity of the disease and the outcome of the infection. This study describes and compares laboratory findings among COVID-19 patients hospitalized at a facility in Southwestern Nigeria according to disease severity and mortality.

Methodology: Records of 223 patients with COVID-19 disease admitted between March 2020 and May 2021 were retrospectively collected. Socio-demographic characteristics, laboratory parameters, and patient outcomes were obtained. Patients were classified according to COVID-19 severity. Laboratory parameters were compared between patients with severe and non-severe disease and between survivors and non-survivors.

Results: Of the 215 patients with some laboratory data included in the analysis, there were 133 (62%) males, and 56.7% were aged above 60 years. A total of 71.6% had severe COVID-19 and 48.4% died during hospitalization. The severe disease occurred significantly more frequently among non-survivors (P0.01). Higher leukocyte and neutrophil counts, urea levels, D-Dimer, and fasting blood glucose levels occurred significantly more frequently in both severe disease and mortality categories. Additionally, elevated GGT and CRP were significantly more common in those with severe than non-severe disease while lower hemoglobin, hematocrit, albumin, and higher creatinine levels were significantly more common in non-survivors.

Conclusion: Our study found that certain readily obtainable biochemical parameters occur more frequently with severe disease and/or mortality amongst patients hospitalized with COVID-19 in sub-Saharan Africa and might be useful for prognostication and allocation of resources.

Keywords: Biochemical Markers; COVID-19; Hematological Indices; SARS-CoV-2.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Showing patients disease severity classification
Figure 2:
Figure 2:
Showing distribution by Clinical outcomes

Similar articles

References

    1. Tcheutchoua DN, Tankeu AT, Angong DLW, Agoons BB, Nguemnang NYY, Djeunga HCN, et al. Unexpected low burden of coronavirus disease 2019 (Covid-19) in sub-saharan africa region despite disastrous predictions: Reasons and perspectives. Pan Afr Med J. 2020; 37:1–15. - PMC - PubMed
    1. Tessema SK, Nkengasong JN. Understanding COVID-19 in Africa. Nat Rev Immunol. 2021; 21:469–70. - PMC - PubMed
    1. Biamonte F, Botta C, Mazzitelli M, Rotundo S, Trecarichi EM, Foti D, et al. Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility. J Transl Med. 2021; 19:1–10. - PMC - PubMed
    1. Wolde M. Hematology, immunology and clinical chemistry profiles of COVID-19 patients: Systematic review. Ethiop J Heal Dev. 2020; 34:226–31.
    1. Qin R, He L, Yang Z, Jia N, Chen R, Xie J, et al. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis. Clinical Reviews in Allergy and Immunology. 2022. - PMC - PubMed

LinkOut - more resources